C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2006
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870988A 2-azetidinones as anti-hypercholesterolemic agents
11/29/2006	CN1286883C Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition
11/29/2006	CN1286833C Indole and 2,3-indoline derivative, their preparation and application
11/29/2006	CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006	CN1286822C Pyrimidinone compounds
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/29/2006	CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/29/2006	CN1286764C Non-heating clay composites for building materials
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141674 Anti-inflammatory compounds
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125208A1 Inhibitors of matrix metalloproteinases
11/23/2006	WO2006123786A1 Cyanine coloring matter and optical recording medium
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006122955A1 New 2-pyridinylcycloalkylcarboxamide derivatives as fungicides.
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases
11/23/2006	WO2006044732A3 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264589 copolymerizing butadiene and styrene in presence of a lithium initiating agent e.g.2-lithio-[4-(4-methylpiperazino)]phenyl-1,3-dithiane for performing living polymerization, terminating the addition copolymer with a terminating agent e.g. tributyltin chloride; molecular weight control
11/23/2006	US20060264496 Substituted indoline and indole derivatives
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264476 Substituted imidazoles and thiazoles; 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl)methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile, antitumor agents
11/23/2006	US20060264474 novel sulphonamide, sulphamate and sulphamide derivatives, comprising a m-disubstituted benzene or pyridine ring and a substituted pyrazole moiety, which inhibit the processing of APP by gamma -secretase, and hence are useful in the treatment or prevention of Alzheimer's disease
11/23/2006	US20060264470 e.g. 4-(4-chlorophenyl)-5-(2,4-dichlorophenyl)-3-methyl-N-piperidin-1-ylthiophene-2-carboxamide; cannabinoid receptor antagonist; antiinflammatory agent; obesity, gastrointestinal disorders, inflammatory phenomena, immune system diseases, psychotic disorders, alcohol and nicotine dependence
11/23/2006	US20060264462 Imidazolamino compounds
11/23/2006	US20060264461 Imidazolamino compounds
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264433 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264430 Pyrazole derivative
11/23/2006	US20060264419 Substituted pyrazoles
11/23/2006	DE60202452C5 Pyridazinonaldose reductase inhibitoren Reductase inhibitors Pyridazinonaldose
11/23/2006	CA2609288A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	CA2608957A1 Pyrrolidine derivative or salt thereof
11/23/2006	CA2605050A1 Histone deacetylase inhibitors
11/22/2006	EP1724269A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724259A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indazol-5-yl)-octan amide derivatives and related compounds as renin inhibitors for the treatment of hypertension
11/22/2006	EP1723164A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
11/22/2006	EP1723142A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723141A2 Industrial process for preparation of clopidogrel hydrogen sulphate
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1723115A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723108A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/22/2006	EP1723105A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1635817B1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
11/22/2006	EP1554243B1 Bicyclic benzamide compounds as histamine h3 receptor ligand useful in the treatment of neurological diseases
11/22/2006	EP1530574B1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments
11/22/2006	EP1501815B1 Substituted phenylacetamides and their use as glucokinase activators
11/22/2006	EP1501798A4 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1399156B1 Alkylidene pirazolidinedione derivatives and their use for treating diabetes and obesity
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1268435B1 4,5-dihydro-1h-pyrazole derivatives having cb 1-antagonistic activity
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867557A Substitute thiophenes and uses therof
11/22/2006	CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1865260A Long chain arylpiperazine modified duloxetine analog compound and preparation and uses
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1865219A 2- and 2,5-substituted phenylketo-enols
11/22/2006	CN1285580C Pyrimidine compounds
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138529 e.g., N-(3-Cyano-4,5-dimethyl-thiophen-2-yl)-2,2-diphenyl-acetamide;3-Methyl-2-phenyl-pentanoic acid-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-amide; or N-(3-Cyano-6-methanesulfonyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridin-2-yl)-2,2-diphenyl-acetamide;
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138396 Treating androgen-dependent diseases, particularly benign prostatic hyperplasia, with a piperidinyl- or piperazinyl- N-(4-substituted pentamethylene)- or N-(4-substituted iminodiethylene)- acetamide derivative, optionally in combination with an alpha-1 adrenergic antagonist
11/21/2006	US7138385 Thioarabinofuranosyl compounds and use thereof
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2187523C Pyranone compounds useful to treat retroviral infections
11/21/2006	CA2140441C Inhibitors of c-amp phosphodiesterase and tnf

1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 523